HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. Insider Trading Activity | OTC:HEPA

HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. Insider Trading Activity | OTC:HEPA | Benzinga

Track the latest HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. insider trading activity. Stay informed on recent buys, sells, and market impact for HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

On April 27, 2026, Vincent S LoPriore, the company's EXECUTIVE CHAIRMAN purchased 6.25M shares for 0.0400 each.
On April 27, 2026, Michael Purcell, the company's DIRECTOR purchased 1.25M shares for 0.0400 each.
On April 27, 2026, Sireesh Appajosyula, the company's DIRECTOR purchased 1.25M shares for 0.0400 each.

Ownership Statistics for HEPION PHARMS INC by Hepion Pharmaceuticals, Inc.

Shares Outstanding

29.119M

Shares Float

17599310.0%

Insider Shares Owned

3.223M

Insider Percentage Owned

27.7%

Institutional Shares Held

709.000

Institutional Percentage Held

0.00%


Apr 27, 2026	Michael Purcell	DIRECTOR	1.25M	$0.04	$50.00K	BUY	∞	1.25M	Apr 21	View
Apr 27, 2026	Vincent S LoPriore	EXECUTIVE CHAIRMAN	6.25M	$0.04	$250.00K	BUY	∞	6.25M	Apr 21	View
Apr 27, 2026	Sireesh Appajosyula	DIRECTOR	1.25M	$0.04	$50.00K	BUY	∞	1.25M	Apr 21	View
Apr 27, 2026	Gary S Stetz	INTERIM CEO	1.25M	$0.04	$50.00K	BUY	∞	1.25M	Apr 21	View
Nov 28, 2023	Peter Wijngaard	DIRECTOR	5.00K	$3.07	$15.35K	BUY	111.09%	9.50K	Nov 24 - Nov 27	View
Sep 20, 2023	Peter Wijngaard	DIRECTOR	3.00K	$5.61	$16.84K	BUY	199.87%	4.50K	Sep 15 - Sep 19	View
Sep 19, 2023	Robert Foster	CEO AND DIRECTOR	1.60K	$5.60	$8.96K	BUY	3.27%	50.47K	Sep 18	View
Sep 18, 2023	Robert Foster	CEO,CSO AND DIRECTOR	1.60K	$5.40	$8.64K	BUY	3.38%	48.87K	Sep 15	View
Feb 18, 2021	Peter Wijngaard	DIRECTOR	10.00K	$2.20	$22.00K	BUY	50.00%	30.00K	Feb 16	View
Feb 18, 2021	Robert Foster	CEO AND DIRECTOR	20.00K	$2.00	$40.00K	BUY	79.18%	45.26K	Feb 18	View
Feb 18, 2021	John Cavan	CHIEF FINANCIAL OFFICER	10.00K	$2.00	$20.00K	BUY	208.33%	14.80K	Feb 18	View
Dec 21, 2020	Peter Wijngaard	—	20.00K	$1.91	$38.20K	PURCHASE	∞	20.00K	Dec 18	View
Dec 08, 2020	Robert Foster	—	25.00K	$1.58	$39.42K	PURCHASE	9652.51%	25.26K	Dec 08	View
Dec 02, 2020	John Brancaccio	—	7.00K	$1.53	$10.71K	PURCHASE	87500.00%	7.01K	Dec 02	View
Dec 01, 2020	Gary Jacob	—	12.00K	$1.66	$19.92K	PURCHASE	20338.98%	12.06K	Dec 01	View
Nov 30, 2020	John Cavan	—	4.50K	$1.62	$7.29K	PURCHASE	1500.00%	4.80K	Nov 25	View

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

HEPA Insider Trading News

Over $18M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed lower on Wednesday following Fed’s rate decision, there were a few notable insider trades.

Lisa Levin

Hepion Pharmaceuticals Director Peter Wijngaard Reported Purchase of 20,000 Shares @ Avg Price of $1.91/Share in Form 4 Filing

Charles Gross

Orin Hirschman Reports 6.9% Passive Stake in Hepion Pharmaceuticals as of November 25 in 13G Filing

Charles Gross